Contract facts
NONENo full NAICS 325414 intel page yet. Browse NAICS intelligence
THE PURPOSE OF THIS MODIFICATION IS TO ACCELERATE THE DELIVER SCHEDULE OF 22.5M DOSES OF ALREADY EXERCISED OPTIONS AND… is a federal NONE award for Department of Defense (DOD) held by Pfizer Inc. Estimated value $11.1B ($2.2B obligated). Current period of performance ends Jun 30, 2023. Last award drew 1 bidder. Place of performance: NEW YORK, NY. Related solicitation W15QKN21R0038.
THE PURPOSE OF THIS MODIFICATION IS TO ACCELERATE THE DELIVER SCHEDULE OF 22.5M DOSES OF ALREADY EXERCISED OPTIONS AND EXERCISE AN ADDITIONAL 50M DOSES WHILE CHANGING THE DELIVERED FORMULATION FROM RTU TO FROZEN FORMULATION.
Recompete timing
PublicCurrent PoP ended Jun 30, 2023 (1198 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on W15QKN21C0012? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordPfizer Inc — $3.2B obligated across 1,961 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W15QKN21C0012?
W15QKN21C0012 (Purpose of THIS modification IS to) is a W6qk Acc-Pica award with an estimated value of $11.1B, currently held by Pfizer Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W15QKN-21-C-0012?
W15QKN-21-C-0012 is the dashed form of PIID W15QKN21C0012 (Purpose of THIS modification IS to), held by Pfizer Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W15QKN21C0012?
W6qk Acc-Pica awarded W15QKN21C0012 to Pfizer Inc.
Who is the incumbent on W15QKN21C0012?
Pfizer Inc is the incumbent with $3.2B across 1961 related awards in SCOUT’s public footprint. The current period of performance ends Jun 30, 2023.
When does Pfizer Inc’s W15QKN21C0012 come up for recompete?
SCOUT tracks a period-of-performance end of Jun 30, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on W15QKN21C0012? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.